A Case of Atypical Skull Base Osteomyelitis Secondary to Otitis Media Due to Delayed Diagnosis

Ze-Ming Fu1, De-Jun Zhang, Guo-Fang Guan

  • 1Department of Otolaryngology-Head and Neck Surgery, Second Hospital, Jilin University, China.

Insights

Skull base osteomyelitis from otitis media is rare but can be fatal in older adults, especially during the COVID-19 pandemic. Early diagnosis and aggressive treatment are crucial for a better prognosis in these challenging cases.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Radiology

Background:

  • Skull base osteomyelitis (SB0) is a rare complication of otitis media, particularly in the antibiotic era.
  • The COVID-19 pandemic has been associated with delayed medical diagnosis and treatment, potentially increasing risks for secondary infections.
  • Otitis media, though common, can lead to severe complications in immunocompromised or elderly patients.

Observation:

  • An 84-year-old male with diabetes presented with atypical skull base osteomyelitis secondary to otitis media.
  • The patient's condition was exacerbated by delayed diagnosis and incomplete treatment during the COVID-19 pandemic.
  • The presentation of SB0 was atypical, posing significant diagnostic challenges.

Findings:

  • This case underscores the potential for otitis media to cause life-threatening skull base osteomyelitis even in the modern medical era.
  • Delayed diagnosis and treatment were identified as key factors contributing to the development of SB0 in this patient.
  • Atypical presentations of SB0 necessitate a high index of suspicion and thorough diagnostic evaluation.

Implications:

  • Healthcare providers must remain vigilant for rare but severe complications of common infections like otitis media, especially in vulnerable populations.
  • Aggressive and timely management of skull base osteomyelitis is essential for improving patient outcomes.
  • This case highlights the importance of prompt medical attention, even for seemingly minor infections, particularly during public health crises like the COVID-19 pandemic.